Stockscreener 앱 받기
36.33
0.57%
-0.25
Cytokinetics Inc 주식(CYTK)의 최신 뉴스
Spinal Muscular Atrophy Market Opportunities and Future Scope - openPR.com
Published on: 2025-08-04 22:46:47 - metal.it
Cytokinetics Incorporated Price Holds Above Key Fib LevelAI Forecast for Trending Stocks Indicates Upside - beatles.ru
What are analysts’ price targets for Cytokinetics Incorporated in the next 12 monthsOutstanding capital growth - Jammu Links News
Cytokinetics Incorporated Stock Analysis and ForecastBuild wealth with long-term growth strategies - Jammu Links News
What makes Cytokinetics Incorporated stock price move sharplyCapitalize on emerging industry trends - Jammu Links News
What is Cytokinetics Incorporated company’s growth strategyMarket-leading capital gains - Jammu Links News
Should I hold or sell Cytokinetics Incorporated stock in 2025Rapid growth opportunities - Jammu Links News
How strong is Cytokinetics Incorporated company’s balance sheetHigh-profit trading signals - Jammu Links News
What are the latest earnings results for Cytokinetics IncorporatedExpert Picks Outlook For Beginners - jammulinksnews.com
CYTK ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Cytokinetics, Incorporated - ACCESS Newswire
Shareholder Rights Advocates at Levi & Korsinsky Investigate Cytokinetics, Incorporated (CYTK) Regarding Possible Securities Fraud Violations - ACCESS Newswire
What institutional investors are buying Cytokinetics Incorporated stockFree Stock Forecasts That Work - jammulinksnews.com
Levi & Korsinsky Announces an Investigation on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Institutional Tools Highlight Unusual Flow in Cytokinetics IncorporatedWeekly Chart Analysis With Entry Advice Provided - metal.it
Raymond James downgrades Cytokinetics stock rating to Market Perform By Investing.com - Investing.com Canada
Cytokinetics, Incorporated Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsCYTK - ACCESS Newswire
Cytokinetics Incorporated Stock Support and Resistance Levels You Should KnowRisk Controlled Picks With Real Returns Outlined - metal.it
Why Cytokinetics Incorporated stock attracts strong analyst attentionEarnings Play Trade Plan With Alerts Shared - metal.it
Cytokinetics Incorporated Earnings Report Breakdown: What Investors Should KnowInvestment Playbook for Growing Markets Shared - metal.it
Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT - MSN
Cytokinetics, Incorporated (CYTK) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire
Cytokinetics Inc. Announces Q2 2025 Financial Results and Conference Call - AInvest
Cytokinetics (CYTK): Is the FDA Delay a Buying Opportunity for Aficamten's Long-Term Payoff? - AInvest
Levi & Korsinsky Reminds Cytokinetics, Incorporated Investors of the Ongoing Investigation into Potential Violations of Securities LawsCYTK - ACCESS Newswire
Cytokinetics Deserves a Speculative Buy Rating - AInvest
Cytokinetics to Announce Second Quarter Results On August 7, 2025 - Yahoo Finance
What risks could impact Cytokinetics Incorporated stock performanceExceptional trading performance - jammulinksnews.com
Top Executive Sells Cytokinetics Stock in a Major Move - TipRanks
What drives Cytokinetics Incorporated stock priceRapid portfolio appreciation - Autocar Professional
What analysts say about Cytokinetics Incorporated stockFree Stock Market Knowledge Sharing - jammulinksnews.com
Is Cytokinetics Incorporated a good long term investmentOutstanding trading profits - Jammu Links News
Shareholders that lost money on Cytokinetics, Incorporated (CYTK) should contact Levi & Korsinsky about Securities Fraud InvestigationCYTK - ACCESS Newswire
Cytokinetics, Incorporated INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Cytokinetics, Incorporated (CYTK) - ACCESS Newswire
Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
0.75%
0.79%
자본화:
|
볼륨(24시간):